Company profile for Genevant Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We leverage our extensive nucleic acid drug delivery and development experience and expertise to develop new medicines for patients who need them. We do this by selectively collaborating with leading pharmaceutical and biotechnology companies who seek access to our platforms, technologies, systems and patent estate. We foster a culture of innovation that keeps us at the forefront of the field. Our unique capabilities provide o...
We leverage our extensive nucleic acid drug delivery and development experience and expertise to develop new medicines for patients who need them. We do this by selectively collaborating with leading pharmaceutical and biotechnology companies who seek access to our platforms, technologies, systems and patent estate. We foster a culture of innovation that keeps us at the forefront of the field. Our unique capabilities provide opportunities to make a dramatic impact on patients’ lives.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
887 Great Northern Way Unit 155 Vancouver, British Columbia V5T
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/03/03/3035733/14025/en/Genevant-Sciences-and-Arbutus-Biopharma-Initiate-International-Patent-Infringement-Enforcement-Actions-Against-Moderna.html

GLOBENEWSWIRE
03 Mar 2025

https://www.fiercebiotech.com/biotech/oncology-biotech-epitopea-licenses-genevant-nucleic-acid-delivery-tech-123-million

FIERCE BIOTECH
20 Dec 2024

https://www.globenewswire.com//news-release/2024/12/19/3000271/0/en/Epitopea-and-Genevant-Sciences-Announce-Collaboration-Agreement.html

GLOBENEWSWIRE
19 Dec 2024

https://www.globenewswire.com/news-release/2024/10/21/2966518/0/en/Editas-Medicine-and-Genevant-Sciences-to-Collaborate-to-Develop-Novel-mRNA-LNP-Gene-Editing-Therapeutics.html

GLOBENEWSWIRE
21 Oct 2024

https://www.fiercebiotech.com/research/repair-licenses-genevants-nucleic-acid-delivery-tech-107m-bring-therapeutic-mrna

FIERCE BIOTECH
27 Sep 2024

https://www.globenewswire.com/news-release/2024/09/26/2953725/0/en/Repair-Biotechnologies-and-Genevant-Sciences-to-Collaborate-to-Develop-mRNA-LNP-Therapy-with-First-in-Class-Potential-to-Turn-Back-Atherosclerosis.html

GLOBENEWSWIRE
26 Sep 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty